+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biopharmaceuticals Contract Manufacturing Market Research Report by Product, Source, Contract Type, Service, Scale of Operation, Therapeutic Applications, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 257 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5613012
UP TO OFF until Dec 31st 2022
The Global Biopharmaceuticals Contract Manufacturing Market size was estimated at USD 27.99 billion in 2021, USD 32.37 billion in 2022, and is projected to grow at a CAGR of 15.92% to reach USD 67.93 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biopharmaceuticals Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Biologics and Biosimilar.
  • Based on Source, the market was studied across Mammalian and Microbial-Based Biologics/Non-Mammalia.
  • Based on Contract Type, the market was studied across Active Pharmaceutical Ingredient (API) and Fill-and-Finished.
  • Based on Service, the market was studied across Analytical & Quality Control Studies, Fill & Finish Operations, Packaging, and Process Development.
  • Based on Scale of Operation, the market was studied across Clinical and Commercial.
  • Based on Therapeutic Applications, the market was studied across Cardiovascular Diseases, Infectious Disease, Neurology, Oncology, Ophthalmology, and Respiratory Disorder.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biopharmaceuticals Contract Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceuticals Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopharmaceuticals Contract Manufacturing Market, including AbbVie, Inc., AGC Biologics, Ajinomoto Co. Inc., Binex Co., Ltd., Boehringer Ingelheim Biopharmaceuticals GmbH, Cambrex Corporation, FUJIFILM Diosynth Biotechnologies U.S.A. Inc, General Electric Co., INCOG BioPharma Services, Inno Bio Ventures Sdn Bhd, JRS Pharma, Lonza AG, Merck KGaA, Pressure BioSciences, ProBioGen AG, Rentschler Biotechnologie GmbH, Samsung Biologics Co. Ltd., Thermo Fisher Scientific, Inc., Toyobo Co. Ltd., and WuXi Biologics, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biopharmaceuticals Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceuticals Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceuticals Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Biopharmaceuticals Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Biopharmaceuticals Contract Manufacturing Market?
6. What is the market share of the leading vendors in the Global Biopharmaceuticals Contract Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceuticals Contract Manufacturing Market?
Frequently Asked Questions about the Global Biopharmaceuticals Contract Manufacturing Market

What is the estimated value of the Global Biopharmaceuticals Contract Manufacturing Market?

The Global Biopharmaceuticals Contract Manufacturing Market was estimated to be valued at $27.99 Billion in 2021.

What is the growth rate of the Global Biopharmaceuticals Contract Manufacturing Market?

The growth rate of the Global Biopharmaceuticals Contract Manufacturing Market is 15.9%, with an estimated value of $67.93 Billion by 2027.

What is the forecasted size of the Global Biopharmaceuticals Contract Manufacturing Market?

The Global Biopharmaceuticals Contract Manufacturing Market is estimated to be worth $67.93 Billion by 2027.

Who are the key companies in the Global Biopharmaceuticals Contract Manufacturing Market?

Key companies in the Global Biopharmaceuticals Contract Manufacturing Market include AbbVie, Inc., AGC Biologics, Ajinomoto Co. Inc., Binex Co., Ltd., Boehringer Ingelheim Biopharmaceuticals GmbH, Cambrex Corporation, FUJIFILM Diosynth Biotechnologies U.S.A. Inc, General Electric Co. and Inno Bio Ventures Sdn Bhd.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising outsourcing by biopharmaceutical companies
5.1.1.2. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
5.1.1.3. Growing demand for biologics globally
5.1.2. Restraints
5.1.2.1. High cost of setting up a production facility for biopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Increasing investments in biopharmaceutical R&D and manufacturing
5.1.3.2. Growing focus on speciality drugs
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for CMOs
5.2. Cumulative Impact of COVID-19
6. Biopharmaceuticals Contract Manufacturing Market, by Product
6.1. Introduction
6.2. Biologics
6.3. Biosimilar
7. Biopharmaceuticals Contract Manufacturing Market, by Source
7.1. Introduction
7.2. Mammalian
7.3. Microbial-Based Biologics/Non-Mammalia
8. Biopharmaceuticals Contract Manufacturing Market, by Contract Type
8.1. Introduction
8.2. Active Pharmaceutical Ingredient (API)
8.3. Fill-and-Finished
9. Biopharmaceuticals Contract Manufacturing Market, by Service
9.1. Introduction
9.2. Analytical & Quality Control Studies
9.3. Fill & Finish Operations
9.4. Packaging
9.5. Process Development
10. Biopharmaceuticals Contract Manufacturing Market, by Scale of Operation
10.1. Introduction
10.2. Clinical
10.3. Commercial
11. Biopharmaceuticals Contract Manufacturing Market, by Therapeutic Applications
11.1. Introduction
11.2. Cardiovascular Diseases
11.3. Infectious Disease
11.4. Neurology
11.5. Oncology
11.6. Ophthalmology
11.7. Respiratory Disorder
12. Americas Biopharmaceuticals Contract Manufacturing Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Biopharmaceuticals Contract Manufacturing Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Biopharmaceuticals Contract Manufacturing Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. AbbVie, Inc.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. AGC Biologics
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Ajinomoto Co. Inc.
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Binex Co., Ltd.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Boehringer Ingelheim Biopharmaceuticals GmbH
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Cambrex Corporation
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. FUJIFILM Diosynth Biotechnologies U.S.A. Inc
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. General Electric Co.
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. INCOG BioPharma Services
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Inno Bio Ventures Sdn Bhd
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. JRS Pharma
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Lonza AG
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Merck KGaA
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Pressure BioSciences
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. ProBioGen AG
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Rentschler Biotechnologie GmbH
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Samsung Biologics Co. Ltd.
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Thermo Fisher Scientific, Inc.
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Toyobo Co. Ltd.
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. WuXi Biologics, Inc.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 11. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 14. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2021 VS 2027 (%)
FIGURE 17. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY SOURCE, 2027
FIGURE 19. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2021 VS 2027 (%)
FIGURE 22. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY CONTRACT TYPE, 2027
FIGURE 24. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2021 VS 2027 (%)
FIGURE 27. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICE, 2027
FIGURE 29. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, 2018-2027 (USD BILLION)
FIGURE 30. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, 2018-2027 (USD BILLION)
FIGURE 32. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2021 VS 2027 (%)
FIGURE 34. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY SCALE OF OPERATION, 2027
FIGURE 36. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2027 (USD BILLION)
FIGURE 37. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, 2018-2027 (USD BILLION)
FIGURE 38. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2021 VS 2027 (%)
FIGURE 39. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC APPLICATIONS, 2027
FIGURE 41. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD BILLION)
FIGURE 42. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2027 (USD BILLION)
FIGURE 43. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, 2018-2027 (USD BILLION)
FIGURE 44. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD BILLION)
FIGURE 45. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, 2018-2027 (USD BILLION)
FIGURE 46. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, 2018-2027 (USD BILLION)
FIGURE 47. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 49. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 50. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 51. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 57. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 58. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 59. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 61. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 62. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 63. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 79. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 90. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 91. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 92. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 93. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 94. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 95. SWEDEN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 96. SWITZERLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 97. TURKEY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 98. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 99. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 100. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 101. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 102. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2018-2027 (USD BILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY REGION, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY REGION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, 2018-2027 (USD BILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD BILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2027 (USD BILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2027 (USD BILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2027 (USD BILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, 2018-2027 (USD BILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD BILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, 2018-2027 (USD BILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, 2018-2027 (USD BILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY REGION, 2018-2027 (USD BILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY REGION, 2018-2027 (USD BILLION)
TABLE 66. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 67. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 68. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 69. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 70. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 71. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 72. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 73. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 74. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 75. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 76. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 77. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 78. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 79. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 80. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 81. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 82. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 83. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 84. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 85. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 86. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 87. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 88. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 89. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 90. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 91. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 92. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 93. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 94. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 95. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 96. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 97. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 98. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 99. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 100. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 101. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 102. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 103. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 104. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 105. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 106. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 107. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 108. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 109. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 110. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 111. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 112. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 113. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 114. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 115. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 116. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 117. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 118. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 119. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 120. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 121. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 122. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 123. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 124. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 125. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 126. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 127. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 128. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 129. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 130. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 131. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 132. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 133. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 134. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 135. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 136. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 137. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 138. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 139. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 140. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 141. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 142. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 143. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 144. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 145. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 146. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 147. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 148. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 149. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 150. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 151. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 152. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 153. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 154. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 155. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 156. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 157. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 158. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 159. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 160. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 161. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 162. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 163. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 164. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 165. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 166. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 167. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 168. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 169. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 170. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 171. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 172. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 173. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 174. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 175. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 176. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 177. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 178. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 179. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 180. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 181. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 182. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 183. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 184. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 185. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 186. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 187. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 188. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 189. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 190. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 191. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 192. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 193. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 194. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 195. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 196. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 197. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 198. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 199. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 200. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 201. VIETNAM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 210. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 211. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 212. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 213. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 214. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 215. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 216. DENMARK BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 217. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 218. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 219. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 220. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 221. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 222. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 223. EGYPT BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 224. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 225. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 226. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 227. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 228. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 229. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 230. FINLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 231. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 232. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 233. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 234. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 235. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 236. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 237. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 238. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 239. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 240. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 241. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 242. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 243. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 244. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 245. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 246. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 247. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 248. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 249. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 250. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 251. ISRAEL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 252. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 253. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 254. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 255. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 256. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 257. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 258. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 259. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 260. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 261. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 262. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 263. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 264. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 265. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 266. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 267. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 268. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 269. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 270. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 271. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 272. NIGERIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 273. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 274. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 275. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 276. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2027 (USD BILLION)
TABLE 277. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2027 (USD BILLION)
TABLE 278. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2018-2027 (USD BILLION)
TABLE 279. NORWAY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD BILLION)
TABLE 280. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 281. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 282. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2027 (USD BILLION)
TABLE 283. POLAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT

Companies Mentioned

  • AbbVie, Inc.
  • AGC Biologics
  • Ajinomoto Co. Inc.
  • Binex Co., Ltd.
  • Boehringer Ingelheim Biopharmaceuticals GmbH
  • Cambrex Corporation
  • FUJIFILM Diosynth Biotechnologies U.S.A. Inc
  • General Electric Co.
  • INCOG BioPharma Services
  • Inno Bio Ventures Sdn Bhd
  • JRS Pharma
  • Lonza AG
  • Merck KGaA
  • Pressure BioSciences
  • ProBioGen AG
  • Rentschler Biotechnologie GmbH
  • Samsung Biologics Co. Ltd.
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co. Ltd.
  • WuXi Biologics, Inc.

Methodology

Loading
LOADING...